Status:
UNKNOWN
Study of Low Molecular Weight Heparins
Lead Sponsor:
Herlev Hospital
Conditions:
Anticoagulant
Venous Thromboembolism
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
DANHEP is a cluster randomized study of two different low molecular weight heparins. Parenteral anticoagulants are used in a variety of settings, including treatment and prevention of venous thromboem...
Eligibility Criteria
Inclusion
- All patients with indication for low molecular weight heparin
Exclusion
- Patients under the age of 18
- Patients who are incapable of understanding the written material received
- Patients who after being informed in writing chooses not to participate
- Patients with contraindications for low molecular weight heparins as described in the SmPC
Key Trial Info
Start Date :
March 23 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 23 2025
Estimated Enrollment :
65000 Patients enrolled
Trial Details
Trial ID
NCT06020560
Start Date
March 23 2023
End Date
March 23 2025
Last Update
August 31 2023
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Amager-Hvidovre Hospital
Copenhagen, Denmark
2
Frederiksberg and Bispebjerg Hospital
Copenhagen, Denmark
3
Rigshospitalet
Copenhagen, Denmark
4
Herlev and Gentofte Hospital
Herlev, Denmark, 2730